Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


Revenue 2017


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Symbicort was produced by AstraZeneca and Astellas.

New Accounts, November, 2006 - Advertising

AstraZeneca. Symbicort (multimedia). Respiratory. RFA Advertising &Marketing. British Medical Journal. Clinical Evidence.

New Accounts, September, 2006 - Advertising

To submit an entry for New Accounts, emailAstraZeneca. Symbicort (multimedia). Respiratory.

Patients prefer AZ asthma drug

Details of a recent study presented at the International Conference of the American Thoracic Society in Toronto showed that asthma patients prefer AstraZeneca's (AZ) Symbicort to GlaxoSmithKline's (GSK) Adviar. ... Patients involved in the open-label

AZ defiant after Symbicort patent revoked

The European Patent Office has upheld an appeal by two generic drug manufactures, Norton Healthcare and Generics UK, and revoked a patent for Symbicort. ... In 2007, sales of Symbicort reached $1.58bn, $1.34bn of which was in the European market.

New sNDA for AZ's Symbicort

AstraZeneca has submitted a supplemental new drug application to the US Food and Drug Administration for its COPD product, Symbicort. ... Patients with moderate-to-severe COPD were given Symbicort during the studies. According to AZ, the medication was

[ Previous 5 results ] 8 9 10 11 12 13 14 15 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...